Aaron Guthrie, MD
Family Medicine · Saint Louis, MONPI 1144361494
Payments from drug & device makers
Across 104 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$264
- AbbVie$211
- Lilly USA, LLC$195
- GSK$150
- Sanofi-aventis U.S. LLC$120
- Amarin Pharma, Inc.$100
- plus $625 from 16 others
What the payments were for
- Food & beverage$1,664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $264 |
| AbbVie | 8 | $211 |
| Lilly USA, LLC | 12 | $195 |
| GSK | 10 | $150 |
| Sanofi-aventis U.S. LLC | 7 | $120 |
| Amarin Pharma, Inc. | 6 | $100 |
| Amgen | 6 | $98 |
| Novartis | 4 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Biohaven Pharmaceuticals, Inc. | 4 | $69 |
| Pfizer | 4 | $53 |
| Astellas Pharma US Inc | 3 | $44 |
| AstraZeneca | 3 | $38 |
| Merck | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Radius Health, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
How this compares
$1,664 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 37 | $549 |
| Atorvastatin Calcium | 72 | $537 |
| Amlodipine Besylate | 84 | $490 |
| ValacyclovirValacyclovir Hcl | 12 | $485 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $424 |
| Lisinopril | 83 | $413 |
| Gabapentin | 21 | $406 |
| Levothyroxine Sodium | 48 | $399 |
| Losartan Potassium | 57 | $385 |
| Rosuvastatin Calcium | 35 | $327 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $293 |
| Simvastatin | 39 | $271 |
| Doxycycline Monohydrate | 22 | $265 |
| Prednisone | 123 | $233 |
| Metoprolol Succinate | 19 | $224 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Saint Louis
- Rupal TrivediSaint Louis$10.6M
- Emily DoucetteSaint Louis$155K
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- Amanda BooneSaint Louis$17K
- David GlickSaint Louis$17K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.